Application of ampelopsin in preparing medicines for treating obesity

A technology of staphylosin and obesity, which is applied in the field of application of staphylosin in the preparation of drugs for treating obesity, and can solve problems such as no obesity

Inactive Publication Date: 2011-06-01
KUNMING MEDICAL UNIVERSITY
View PDF1 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Modern experimental studies have shown that staphylophyllin has various pharmacological activities such as antibacterial and anti-inflammatory, anti-oxidation, anti-tumor, liver protection and hypoglycemic [Li Cuiping, Cao Shuwen, Yu Yanying. Research progress of dihydromyricetin[J]. Chemical Reagent. 2010, 32 (7): 608~ 612. Yang Xuemin, Chen Lifeng. Research progress on the biological activity of dihydromyricetin [J]. Chinese Medicine Herald. 2008,14(12):86-89. Yang Zhenhuai, Guo Jiewen, Pan Jingqiang, Li Guanning. Snake Grape Studies on the pharmacological effects of plants of the genus anti-tumor, anti-oxidation, liver protection and blood lipid regulation [J]. Chinese Medicine Research. 2004, 17(4): 57-58], but there is no report that it can be used to treat obesity

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of ampelopsin in preparing medicines for treating obesity
  • Application of ampelopsin in preparing medicines for treating obesity
  • Application of ampelopsin in preparing medicines for treating obesity

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0017] 1. Application of staphylophyllin in the preparation of medicines for the treatment of obesity

[0018] Stapelin is used as a medicine or health product for treating obesity.

[0019] Staphylocin is used for preparing oral tablets or capsules or granules or granules or oral liquids or slow-release preparations or drop pills or injections for treating obesity, as well as conventional dosage forms acceptable in pharmacy.

[0020] 2. The influence of staphylophyllin of the present invention on the body weight of overweight mice

[0021] 40 male Kunming mice were randomly divided into 4 groups, 10 in each group, which were the blank control group, the high-dose 50.0 mg / kg group of ostrapin, the 25.0 mg / kg medium-dose Dose 12.5 mg / kg group. Each group was prepared with 0.5% carboxymethylcellulose sodium (CMC-Na), administered orally at 20 ml / kg once a day for 15 days, and weighed every 3 days.

[0022] The result is as figure 1 As shown, after the administration of stap...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses application of ampelopsin in preparing medicines for treating obesity, and relates to preparation and application of flavonoids compounds. The ampelopsin is used for preparing medicines or health products for treating the obesity, including oral tablets, capsules, granules, oral solution, sustained-release agents, pills and injection solution for treating the obesity, and pharmaceutically acceptable conventional formulations. The ampelopsin has obvious weight-losing effect on obese mice and overweight mice induced by high-fat diet; after the ampelopsin is poured into stomachs of the obese mice in a dose of 25.0mg / kg for 2 weeks, the abdominal fat is obviously reduced, shoulder fat cells are obviously shrunk, the weight is reduced to be normal, and the mice are generally good in conditions, freely acts and have smooth hairs. The maximum tolerance does of the mice through stomach perfusion can reach 18g / kg.

Description

technical field [0001] The invention belongs to the preparation and application of flavonoids, in particular to the application of staphylophyllin in treating obesity. Background technique [0002] Obesity is an unhealthy state of body fat accumulation and weight gain due to calorie intake exceeding consumption. The incidence of obesity is increasing rapidly in both developed countries and developing countries, and it is showing a trend of younger age. It has become a global epidemic that seriously affects health [Xu Manyin, editor-in-chief. Diabetology. Shanghai Science and Technology Press. 2010, Second Edition, p121], at present, there are at least 200-300 million overweight people in my country, and over 70 million people with obesity [Chen Xiuqing. Obesity and its drug treatment. Chinese Medicine Guide. 2010; 32(8): 36- 37]. [0003] Obesity not only affects people's daily life, but also is the main factor leading to diseases such as type 2 diabetes, coronary heart dise...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/352A61P3/04A23L1/30A23L33/105
Inventor 李玲牛艳芬刘旭姜润生林华卢威秦晓改
Owner KUNMING MEDICAL UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products